The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115372223 11537222 3 F 20160711 20150922 20160719 PER PHEH2015US017973 NOVARTIS 0.00 F Y 0.00000 20160719 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115372223 11537222 1 PS GLEEVEC IMATINIB MESYLATE 1 Oral 400 MG, UNK U 21588 400 MG
115372223 11537222 2 SS GLEEVEC IMATINIB MESYLATE 1 Oral 600 MG, QD U S0014 21588 600 MG QD
115372223 11537222 3 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 Unknown 100 MG, TID U 0 100 MG TID
115372223 11537222 4 C ZOLOFT SERTRALINE HYDROCHLORIDE 1 Unknown UNK (REPORTED AS 4, 2 AM/2 PM) U 0 QD
115372223 11537222 5 C AMBIEN ZOLPIDEM TARTRATE 1 Unknown 2 DF, QD (2 DAILY IN PM) U 0 2 DF QD
115372223 11537222 6 C ONGLYZA SAXAGLIPTIN HYDROCHLORIDE 1 Unknown U 0
115372223 11537222 7 C KLONOPIN CLONAZEPAM 1 Oral 6 DF, QD Y 0 6 DF QD
115372223 11537222 8 C KLONOPIN CLONAZEPAM 1 Oral 4 DF, QD Y 0 4 DF QD
115372223 11537222 9 C KLONOPIN CLONAZEPAM 1 Oral 3 DF, QD Y 0 3 DF QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115372223 11537222 1 Neoplasm malignant
115372223 11537222 3 Depression
115372223 11537222 4 Depression
115372223 11537222 5 Sleep disorder
115372223 11537222 6 Diabetes mellitus
115372223 11537222 7 Depression

Outcome of event

Event ID CASEID OUTC COD
115372223 11537222 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
115372223 11537222 Abdominal pain
115372223 11537222 Bone pain
115372223 11537222 Confusional state
115372223 11537222 Decreased appetite
115372223 11537222 Diarrhoea
115372223 11537222 Fatigue
115372223 11537222 Fluid retention
115372223 11537222 Haemorrhage
115372223 11537222 Memory impairment
115372223 11537222 Mental impairment
115372223 11537222 Muscle spasms
115372223 11537222 Nausea
115372223 11537222 Pain
115372223 11537222 Rash
115372223 11537222 Red blood cell count decreased
115372223 11537222 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found